- RecruitingPHASE3
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
This study is for people who have already taken part in other studies for a medicine called sotatercept, used to treat Pulmonary Arterial Hypertension (PAH). It aims to check the long-term safety and how well people tolerate sotatercept when taken with their usual PAH treatments.
For: Pulmonary Arterial HypertensionUnited States · Argentina · Australia - RecruitingPHASE2
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
This study is looking at a new medicine called sotatercept for children aged 1 to 17 with a serious lung condition called pulmonary arterial hypertension (PAH). We want to see if it's safe and how the body handles it over 24 weeks, alongside their usual PAH treatments.
For: Pulmonary Arterial HypertensionUnited States · Australia · Colombia - RecruitingPHASE4
Sotatercept in Pulmonary Arterial Hypertension
This study looks at a new drug, sotatercept, for pulmonary arterial hypertension (PAH). We want to see if it improves how well your lungs take up oxygen, especially during exercise. This could help people with PAH feel better and have more energy.
For: Pulmonary Artery HypertensionCanada - Active not recruitingPHASE2
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION)
This study is looking into a new treatment called sotatercept for pulmonary arterial hypertension (PAH). It's an extension of a previous study. The main aim is to see if sotatercept, given in doses based on weight groups, is safe and can be tolerated by people with PAH over a longer time.
For: Pulmonary Arterial HypertensionUnited States · Argentina · Australia - Active not recruitingPHASE4
Pulmonary Hypertension: Intensification and Personalisation of Combination Rx
This study aims to improve treatment for a serious lung condition called Pulmonary Arterial Hypertension (PAH). Researchers are using tiny implanted devices and approved medications to see if personalised changes to treatment plans can be quickly and effectively monitored at home.
For: Pulmonary Arterial HypertensionUnited Kingdom - Active not recruitingPHASE2
Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)
This study looks at a new medicine called sotatercept for a specific type of high blood pressure in the lungs (Cpc-PH) linked to heart failure. It's for people who were in a previous study to see how the medicine works long-term and if it's safe.
For: Hypertension, PulmonaryUnited States · Belgium · Canada